[go: up one dir, main page]

WO2000014251A3 - Transferases humaines - Google Patents

Transferases humaines Download PDF

Info

Publication number
WO2000014251A3
WO2000014251A3 PCT/US1999/020989 US9920989W WO0014251A3 WO 2000014251 A3 WO2000014251 A3 WO 2000014251A3 US 9920989 W US9920989 W US 9920989W WO 0014251 A3 WO0014251 A3 WO 0014251A3
Authority
WO
WIPO (PCT)
Prior art keywords
trnsfs
transferase proteins
human transferase
provides
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/020989
Other languages
English (en)
Other versions
WO2000014251A2 (fr
Inventor
Y Tom Tang
Neil C Corley
Karl J Guegler
Mariah R Baughn
Preeti Lal
Henry Yue
Jennifer L Hillman
Yalda Azimzai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Priority to US09/786,240 priority Critical patent/US6558935B1/en
Priority to AU61428/99A priority patent/AU6142899A/en
Priority to JP2000568992A priority patent/JP2004512804A/ja
Priority to EP99948200A priority patent/EP1109917A2/fr
Priority to CA002343351A priority patent/CA2343351A1/fr
Publication of WO2000014251A2 publication Critical patent/WO2000014251A2/fr
Publication of WO2000014251A3 publication Critical patent/WO2000014251A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des transférases humaines (TRNFS) et des polynucléotides qui identifient et codent les TRNFS. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne enfin le diagnostic, le traitement et la prévention de troubles liés à l'expression des TRNFS.
PCT/US1999/020989 1998-09-10 1999-09-09 Transferases humaines Ceased WO2000014251A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US09/786,240 US6558935B1 (en) 1998-09-10 1999-09-09 Human transferase proteins
AU61428/99A AU6142899A (en) 1998-09-10 1999-09-09 Human transferase proteins
JP2000568992A JP2004512804A (ja) 1998-09-10 1999-09-09 ヒト転移酵素タンパク質
EP99948200A EP1109917A2 (fr) 1998-09-10 1999-09-09 Transferases humaines
CA002343351A CA2343351A1 (fr) 1998-09-10 1999-09-09 Transferases humaines

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US15065798A 1998-09-10 1998-09-10
US09/150,657 1998-09-10
US18677998A 1998-11-04 1998-11-04
US09/186,779 1998-11-04
US13364298P 1998-11-11 1998-11-11
US60/133,642 1999-05-11

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09/786,240 A-371-Of-International US6558935B1 (en) 1998-09-10 1999-09-09 Human transferase proteins
US10/427,631 Division US20030175923A1 (en) 1998-09-10 2003-04-29 Human transferase proteins

Publications (2)

Publication Number Publication Date
WO2000014251A2 WO2000014251A2 (fr) 2000-03-16
WO2000014251A3 true WO2000014251A3 (fr) 2000-08-03

Family

ID=27384457

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/020989 Ceased WO2000014251A2 (fr) 1998-09-10 1999-09-09 Transferases humaines

Country Status (2)

Country Link
AU (1) AU6142899A (fr)
WO (1) WO2000014251A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7628989B2 (en) 2001-04-10 2009-12-08 Agensys, Inc. Methods of inducing an immune response

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6265192B1 (en) 1998-03-20 2001-07-24 The Regents Of The University Of California Glycosly sulfortransferase-3
US6365365B1 (en) * 1998-03-20 2002-04-02 The Regents Of The University Of California Method of determining whether an agent modulates glycosyl sulfotransferase-3
CN1301748A (zh) * 1999-12-29 2001-07-04 复旦大学 一种新的多肽——生长激素蛋白家族10和编码这种多肽的多核苷酸
AU2001245490A1 (en) * 2000-03-07 2001-09-17 Millennium Pharmaceuticals, Inc. 26886, a novel carnitine acyltransferase family member and uses therefor
EP1341917A2 (fr) * 2000-09-01 2003-09-10 Millennium Pharmaceuticals, Inc. 26199, 33530, 33949, 47148, 50226, et 58764, membres de la famille des transferases humaines et utilisations de ceux-ci
JP4274792B2 (ja) 2000-10-06 2009-06-10 キリンホールディングス株式会社 新規ｎ−アセチルグルコサミニルトランスフェラーゼ、及びそれをコードするポリヌクレオチド
US7045317B2 (en) * 2001-04-04 2006-05-16 University Of Iowa Research Foundation Bardet-biedl susceptibility gene and uses thereof
EP1589985A4 (fr) 2003-02-04 2007-06-06 Millennium Pharm Inc Procede et compositions pour traiter la douleur et les troubles douloureux en utilisant 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620
WO2005030947A2 (fr) * 2003-09-30 2005-04-07 Evotec Neurosciences Gmbh Utilisation diagnostique et therapeutique d'une sulfotransferase pour des maladies neurodegeneratives
EE200900067A (et) 2007-02-06 2009-12-15 Dalhousie University Mutatsioonid inimese UBIAD1-s
AU2011258425B2 (en) 2010-05-27 2015-12-10 Merck Sharp & Dohme Llc Method for preparing antibodies having improved properties
EP2714732A4 (fr) 2011-05-25 2014-12-10 Merck Sharp & Dohme PROCÉDÉ DE PRÉPARATION DE POLYPEPTIDES CONTENANT Fc À PROPRIÉTÉS AMÉLIORÉES
CN115786320B (zh) * 2022-12-21 2025-07-22 江南大学 一种基于自组装策略构建固定化酶合成磺酸基供体paps的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018938A1 (fr) * 1996-10-30 1998-05-07 Incyte Pharmaceuticals, Inc. Spermidine/spermine n1-acetyl transferase d'origine humaine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018938A1 (fr) * 1996-10-30 1998-05-07 Incyte Pharmaceuticals, Inc. Spermidine/spermine n1-acetyl transferase d'origine humaine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CRAVATT ET AL.: "A second mammalian N-myristoyltransferase", EMBL SEQUENCE DATABASE, 6 April 1998 (1998-04-06), HEIDELBERG DE, XP002128928 *
GIANG ET AL.: "A second mammalian N-myristoyltransferase", EMBL SEQUENCE DATABASE, 15 December 1999 (1999-12-15), HEIDELBERG DE *
GIANG ET AL.: "A second mammalian N-myristoyltransferase", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 273, no. 12, March 1998 (1998-03-01), pages 6595 - 6598, XP002128927 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7628989B2 (en) 2001-04-10 2009-12-08 Agensys, Inc. Methods of inducing an immune response
US7641905B2 (en) 2001-04-10 2010-01-05 Agensys, Inc. Methods of inducing an immune response

Also Published As

Publication number Publication date
WO2000014251A2 (fr) 2000-03-16
AU6142899A (en) 2000-03-27

Similar Documents

Publication Publication Date Title
WO1999061471A3 (fr) Proteines transmembranaires humaines
WO2001012662A3 (fr) Proteines associees a la membrane
WO2000015793A3 (fr) Proteines gpcr humaines
WO2000022143A3 (fr) Homologues de proteines kinases
WO2000018922A3 (fr) Proteines humaines associees a des glucides
WO2000034477A3 (fr) Proteines associees a des neurones
WO2000021988A3 (fr) Proteine humaine de la famille des ankyrines
WO1999058692A3 (fr) Proteines associees a l'apoptose humaine
WO2000012711A8 (fr) Proteines membranaires de canal humaines
WO2000009709A3 (fr) Proteases et proteines associees
WO2001020004A3 (fr) Proteines phosphatase et proteines kinase
WO2000012703A3 (fr) Molecules associees au transport de proteines
WO2000026245A3 (fr) Proteines de transport membranaire
WO2000014251A3 (fr) Transferases humaines
WO2000017355A3 (fr) Proteines humaines associees au cytosquelette
WO2000052151A3 (fr) Proteines de secretion humaines
WO2000000594A3 (fr) Transferases humaines
WO1999058558A3 (fr) Proteines de signalisation cellulaire
WO1999061614A3 (fr) Proteines socs humaines
WO2001032888A3 (fr) Molecules humaines de la transferase
WO2000031263A3 (fr) Proteines associees a la gtpase
WO2000015770A3 (fr) Serine/threonine proteines-kinases
WO2000028045A3 (fr) Hydrolases humaines
WO1999038981A3 (fr) Molecules de proteine kinase humaines
WO2000065054A3 (fr) Proteines humaines associees aux membranes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 1999948200

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2343351

Country of ref document: CA

Ref country code: JP

Ref document number: 2000 568992

Kind code of ref document: A

Format of ref document f/p: F

Ref country code: CA

Ref document number: 2343351

Kind code of ref document: A

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 1999948200

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09786240

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1999948200

Country of ref document: EP